How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals [Investor's Business Daily]
InMode Ltd. - Ordinary Shares (INMD)
Last inmode ltd. - ordinary shares earnings: 2/18 08:00 am
Check Earnings Report
Company Research
Source: Investors Business Daily
Related news 8/15/2019 InMode stock popped for a second day running Thursday after the Paula Abdul-backed medical aesthetics company reported strong revenue growth... Pfizer Stock Is A Top Pharma Company — But Should You Buy It? Biotech Crashes 29% After Bad Drug Likely Skewed Cancer Tests Stock Market Rally Stumbles On Trade War Fears; Uber Falls On Massive Loss Roche Meets 80-Plus Relative Strength Rating Benchmark Another Biotech Stock Halted As Manufacturing Issue Comes To Light AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It? BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It? Animal-Health Stock Jumps To Record High As Spending On Fido Grows Merck stock jumped Friday after an analyst initiated coverage of the Dow Jones pharma giant with an outperform rating, citing "the Keytruda wave." By 2027, nearly half of Merck 's ( MRK ) revenue will come from cancer treatments, SVB Leerink analyst D
Show less
Read more
Impact Snapshot
Event Time:
INMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INMD alerts
High impacting InMode Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
INMD
News
- Lifshitz Law PLLC Announces Investigations of InMode Ltd. (NASDAQ: INMD), General Motors Company (NYSE: GM), Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX), and Driven Brands Holdings Inc. (NASDAQ: DRVN)Accesswire
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2024 in InMode Lawsuit - INMDAccesswire
- INMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMDPR Newswire
- Levi & Korsinsky Reminds InMode Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2024 - INMDAccesswire
- DEADLINE ALERT for INMD, AMPL, and NOVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersGlobeNewswire
INMD
Earnings
- 2/13/24 - Beat
INMD
Sec Filings
- 4/4/24 - Form 6-K
- 2/13/24 - Form SC
- 2/13/24 - Form SC
- INMD's page on the SEC website